UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024569
Receipt number R000028262
Scientific Title A cross-sectional investigation of Hand-Foot Syndrome and risk events in cancer patients undergoing chemotherapy
Date of disclosure of the study information 2016/11/07
Last modified on 2018/04/28 12:11:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A cross-sectional investigation of Hand-Foot Syndrome and risk events in cancer patients undergoing chemotherapy

Acronym

A cross-sectional investigation of Hand-Foot Syndrome and risk events in cancer patients undergoing chemotherapy

Scientific Title

A cross-sectional investigation of Hand-Foot Syndrome and risk events in cancer patients undergoing chemotherapy

Scientific Title:Acronym

A cross-sectional investigation of Hand-Foot Syndrome and risk events in cancer patients undergoing chemotherapy

Region

Japan


Condition

Condition

Cancer

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Hematology and clinical oncology
Gastrointestinal surgery Breast surgery Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Study purpose: Focusing on the hand-foot syndrome associated with chemotherapy, to investigate a situation of risk events (falls, external injury, burn injury, etc.) and an association with physical activities and the QOL (Quality of Life).

Basic objectives2

Others

Basic objectives -Others

Risk events (falls, external injury, burn injury, etc.)
Physical activities
QOL
Psychology

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

risk events (falls, external injury, burn injury, etc.)

Key secondary outcomes

QOL(EQ-5D,DLQI)
Physical activities(IPAQ)
Psychology(K6)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patient aged 20 or more (no upper age limit)
2)Patient who is able to complete to the questionnaire in Japanese.
3)Patient with the chemotherapy induced hand-foot syndrome (CTCAE Grade 1 or more)
4)Stage and metastasis are no object.

Key exclusion criteria

1)ECOG performance status 3 or more

2)Patient decided by primary doctor that it's difficult to participate in the research because of cognitive impairment or mental disorders

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroko Komatsu

Organization

Keio University

Division name

Faculty of Nursing and Medical Care

Zip code


Address

35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

TEL

03-5363-3733

Email

komah@sfc.keio.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kaori Yagasaki

Organization

Keio University

Division name

Faculty of Nursing and Medical Care

Zip code


Address

35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

TEL

03-5363-2157

Homepage URL


Email

yagasaki@sfc.keio.ac.jp


Sponsor or person

Institute

Faculty of Nursing and Medical Care, Keio University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAENHI Grant Number 16H02696

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 07 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 03 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 10 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Risk events (falls, external injury, burn injury, etc.)
Physical activities
QOL
Psychology


Management information

Registered date

2016 Year 10 Month 26 Day

Last modified on

2018 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028262


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name